IARC collaborates with the JRC to release first EU cervical cancer screening recommendations
New guidelines to improve screening standards
Cervical Cancer Screening
IARC, in collaboration with the Joint Research Centre (JRC), published the first official set of recommendations for cervical cancer screening in the European Union. The guidelines suggest prioritizing HPV testing as the primary method, redefining the target age group (25–65 years), and improving monitoring systems. The aim is to optimize preventive interventions, avoid unnecessary screenings in non-indicated age groups, and ensure equity and cost-effectiveness across national health systems.
The EC-CvC aims to update cervical cancer screening guidelines to inform patients, health professionals, and policy-makers.
#EuCanScreen #CancerScreening #HealthCare #CancerPrevention #CervicalCancer #IARC
🔗 Please don’t forget to Subscribe to EuCanScreen Newsletter! 💪
Subscribe to our newsletter to get news and updates.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959